Dagmar Kubitza
Dagmar Kubitza publishes mostly in Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine, on topics such as Atrial Fibrillation Management and Outcomes, Blood Coagulation and Thrombosis Mechanisms and Venous Thromboembolism Diagnosis and Management.
- World rank
- #101,371 of 7,710,434 ranked researchers
- Rank in Germany
- #5,426 of 364,343
- Works
- 95
- Citations
- 9.2k
- Citations per work
- 97.2
What does Dagmar Kubitza research?
Dagmar Kubitza's work is mostly in Medicine (75%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7174.9%
- Medicine7174.9%
- Everything else2122.2%
- Life Sciences32.9%
- 1Cardiology and Cardiovascular Medicine29% of their works
- 2Hematology19% of their works
- 3Internal Medicine17% of their works
- 4Pharmacology6% of their works
- 5Epidemiology4% of their works
- 6Molecular Medicine3% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Blood Coagulation and Thrombosis Mechanisms
- Venous Thromboembolism Diagnosis and Management
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotic Resistance in Bacteria
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Heparin-Induced Thrombocytopenia and Thrombosis
Which keywords describe Dagmar Kubitza's research?
The keywords of their largest research topics: Antithrombotic Therapy, Catheter Ablation, Anticoagulant Therapy, Atrial Fibrillation, Diagnosis, Protease-Activated Receptors, Thrombin and Pulmonary Embolism.
- Heparin-Induced Thrombocytopenia
- Aspirin
- Multidrug-Resistant Bacteria
- Antibiotic Resistance
- Antibiotic Pharmacokinetics
- Pulmonary Embolism
- Protease-Activated Receptors
- Atrial Fibrillation
- Catheter Ablation
- Antithrombotic Therapy
- Anticoagulant Therapy
- Diagnosis
- Thrombin
- Venous Thromboembolism
- Critically Ill Patients
- Arrhythmias
- Ventricular Tachycardia
- Clopidogrel
- Thrombosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Antithrombotic Therapy962 topics
- Catheter Ablation612 topics
- Anticoagulant Therapy531 topic
- Atrial Fibrillation531 topic
- Diagnosis532 topics
- Protease-Activated Receptors491 topic
- Thrombin491 topic
- Pulmonary Embolism471 topic
- Venous Thromboembolism471 topic
- Antibiotic Pharmacokinetics171 topic
- Critically Ill Patients171 topic
- Antibiotic Resistance81 topic
- Arrhythmias81 topic
- Multidrug-Resistant Bacteria81 topic
- Ventricular Tachycardia81 topic
- Aspirin71 topic
- Clopidogrel71 topic
- Heparin-Induced Thrombocytopenia61 topic
- Thrombosis61 topic
Where does Dagmar Kubitza work?
Dagmar Kubitza's main affiliation in the publication record is Bayer (Germany), Germany.
How many publications and citations does Dagmar Kubitza have?
OpenAlex counts 95 works and 9,235 citations for Dagmar Kubitza, an h-index of 45, ranking #101,371 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Dagmar Kubitza. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.